Multicenter phase II study of adding bi-weekly cetuximab to oral S-1 therapy in advanced colorectal cancer who have failed prior oxaliplatin and irinotecan-based therapies
收藏NIAID Data Ecosystem2026-03-07 收录
下载链接：
https://www.omicsdi.org/dataset/ecrin-mdr-crc/2621958
下载链接
链接失效反馈官方服务：
资源简介：
Interventions: adding bi-weekly cetuximab to oral S-1 therapy
Primary outcome(s): Progression free survival
Study Design: Single arm Non-randomized
创建时间：
2011-10-15
